MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-MH-18-0048984
Infugen Pharma Private Limited - pharma in Sangli, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹29.66 Cr
▼ 21% YoY
Net profit · FY 2025
₹60.86 Lakh
Net margin 2.1%
EBITDA · FY 2025
₹1.78 Cr
EBITDA margin 6%
Authorised capital
₹30 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹20.1 Cr
Satisfied ₹1.6 Cr
Company age
27 yrs
Est. 1999
Directors on board
2
As per MCA filings
About Infugen Pharma Private Limited
Data last updated:
Infugen Pharma Private Limited is a private limited company based in Sangli, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 04 February 1999 and has been in existence for over 27 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24231PN1999PTC013295. Its GSTIN is 27AABCI2131G1Z1 (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹10 Lakh. It was formerly known as Jeshika Pharma Private Limited. It is led by directors Sandeep Jagjeevan Modi and Bharat Jagjivan Bhate.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Yashokamalharbhat Road Opp Sangli Urban Co – Op Bank Ltd, Maharashtra, India – 416416.
As per the financials filed for FY 2025, the company reported a revenue of ₹29.66 Cr, a decline of 21% compared to the previous year. For the same year it recorded a net profit of ₹60.86 Lakh (net margin 2.1%) and EBITDA of ₹1.78 Cr (EBITDA margin 6%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 21% over five years.
The company is associated with 1 brand: Infugen. As per MCA filings, the company has open charges of ₹20.1 Cr and satisfied charges of ₹1.6 Cr on record. Court records list 1 case involving the company, including 1 filed against it.
Infugen Pharma Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MH-18-0048984). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website infugenpharma.com.
Company details
CIN U24231PN1999PTC013295
Registration Number 013295
Incorporation Date 04 February 1999
ROC Pune
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-MH-18-0048984
Recognitions & Rankings of Infugen Pharma
Contact details
Infugen Pharma Private Limited's registered office is in Sangli, Maharashtra. Its website is infugenpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressYashokamalharbhat Road Opp Sangli Urban Co – Op Bank Ltd, Maharashtra, India – 416416
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Infugen Pharma Private Limited, buy the company report.
Comprehensive company report
Infugen Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Infugen Pharma operates one associated brand: Infugen. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Exporting of pharmaceutical formulations and medical devices is conducted by Infugen in the healthcare sector. | infugenpharma.com |
Business activity
The main business activity of Infugen Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Infugen Pharma Private Limited, buy the company report.
Financials of Infugen Pharma Private Limited
FY 2024 filings availableInfugen Pharma Private Limited reported revenue of ₹29.66 Cr (down 21% YoY) for FY 2025.
Revenue · FY 2025
₹29.66 Cr ▼ 21%
Net profit · FY 2025
₹60.86 Lakh margin 2.1%
EBITDA · FY 2025
₹1.78 Cr margin 6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 21%
3 years · compounded
▼ 2%
5 years · compounded
▲ 21%
EBITDA CAGR growth
1 year
▼ 34%
3 years · compounded
▼ 4%
5 years · compounded
▲ 24%
Revenue fell 21% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 21%. EBITDA fell 34% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.78 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹60.86 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6% | ||||
| Net Profit Margin | 2.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Infugen Pharma Private Limited, buy the company report.
Board of directors of Infugen Pharma Private Limited
Infugen Pharma has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sandeep Jagjeevan Modi | Director | 04 Feb 1999 | 27 Years 9 Months | Current |
| Bharat Jagjivan Bhate Also directs: Infugen Life Sciences Private Limited | Director | 04 Feb 1999 | 27 Years 9 Months | Current |
Peer comparison
Infugen Pharma Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Usan Pharmaceuticals Private Limited | ₹29.79 Cr (FY 2025) | -7.0% | Mumbai, Maharashtra, India | |||
| Nemus Pharmaceuticals Private Limited | ₹29.76 Cr (FY 2025) | 21.0% | Kahalapur, Maharashtra, India | |||
| Cedric Pharmaceuticals Private Limited | ₹29.69 Cr (FY 2025) | 15.0% | Delhi, India | |||
| Infugen Pharma Private Limitedthis company | ₹29.66 Cr (FY 2025) | ₹60.86 Lakh | 2.1% | -21.0% | Sangli, Maharashtra, India | |
| Growmax Medicare Private Limited | ₹29.58 Cr (FY 2025) | 7.0% | New Delhi, Delhi, India | |||
| Maple Cross Remedies Private Limited | ₹29.57 Cr (FY 2024) | -5.0% | Mumbai, Maharashtra, India | |||
| Madhya Pradesh Public Health Services Corporation Limited | ₹29.27 Cr (FY 2023) | -5.0% | Bhopal, Madhya Pradesh, India | |||
| Dellarex Biotec Private Limited | ₹29.19 Cr (FY 2025) | 34.0% | Thane, Maharashtra, India |
To see the full peer comparison of Infugen Pharma Private Limited, buy the company report.
Auditor
Infugen Pharma Private Limited is audited by ABHYANKAR & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ABHYANKAR & CO. | FY 2023 | 100024W |
Shareholding
The shareholding of Infugen Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Infugen Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹20.1 Cr
Satisfied charges
₹1.6 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 May 2025 | 101099753 | Others | ₹1 Cr | Open | |
| 30 Dec 2021 | 100530024 | Others | ₹1.35 Cr | Open | |
| 28 Sep 2020 | 100385297 | Others | ₹10 Cr | Open | |
| 19 Mar 2020 | 100335510 | Others | ₹3.5 Cr | Open | |
| 20 Mar 2012 | 10346871 | Others | ₹4.25 Cr | Open |
To see the full charge records of Infugen Pharma Private Limited, buy the company report.
Total charge records: 7 View all charges
Legal cases
Infugen Pharma Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Total cases
1
Filed against the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| Supreme Court | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Supreme Court | Court case (0428-Indirect Taxes Matters : Others) | Filed against the company by Union of India Through Its Secretary(Revenue) Department of Revenue, Ministry of Finance, Government of India, North Block ,New Delhi , Delhi and 1 other | Disposed |
To see the full case history of Infugen Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Infugen Pharma Private Limited was last rated by Crisil on 08 Apr 2017.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 08 Apr 2017 |
To see the full credit ratings and regulatory alerts of Infugen Pharma Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Infugen Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Infugen Pharma has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCI2131G1Z1 | Maharashtra | Active | 01 Jul 2017 |
| 02AABCI2131G1ZD | Himachal Pradesh | Active | 10 Apr 2023 |
To see the full GST registrations and return filing status of Infugen Pharma Private Limited, buy the company report.
Recent activity
Infugen Pharma Private Limited has 2 board changes on record since 1999: 2 appointments. The latest: Bharat Jagjivan Bhate was appointed as Director on 04 Feb 1999.
Charges
A charge with Others of Rs. 1,000.00 Lakh registered on 28 Sep 2020 with Charge ID 100385297 was modified on 11 Sep 2025.
Charges
A charge with Others amounted to Rs. 100.00 Lakh with Charge ID 101099753 was registered on 21 May 2025.
AGM
Infugen Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge registered on 02 Aug 2017 via Charge ID 100115665 with Others was fully satisfied on 24 Apr 2024.
Charges
A charge registered on 01 Sep 2004 via Charge ID 80061619 with Sangli Urban Co-Operative Bank Limited was fully satisfied on 24 Apr 2024.
Charges
A charge with Others of Rs. 350.00 Lakh registered on 19 Mar 2020 with Charge ID 100335510 was modified on 06 Apr 2024.
Filing
Infugen Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune.
Charges
A charge with Others amounted to Rs. 135.00 Lakh with Charge ID 100530024 was registered on 30 Dec 2021.
Charges
A charge with Others amounted to Rs. 1,000.00 Lakh with Charge ID 100385297 was registered on 28 Sep 2020.
Charges
A charge with Others amounted to Rs. 350.00 Lakh with Charge ID 100335510 was registered on 19 Mar 2020.
Charges
A charge with Others of Rs. 425.00 Lakh registered on 20 Mar 2012 with Charge ID 10346871 was modified on 06 Feb 2018.
Charges
A charge with Others amounted to Rs. 110.00 Lakh with Charge ID 100115665 was registered on 02 Aug 2017.
6 earlier events are in the company report.
Frequently asked questions
Infugen Pharma is an active private limited company based in Sangli, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 04 February 1999 (27+ years old) and is registered under CIN U24231PN1999PTC013295.
Infugen Pharma has 2 current directors:
- Sandeep Jagjeevan Modi - Director
- Bharat Jagjivan Bhate - Director
The latest financial statements of Infugen Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Infugen Pharma is 27AABCI2131G1Z1, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 02AABCI2131G1ZD (Himachal Pradesh).
The CIN (Corporate Identification Number) of Infugen Pharma is U24231PN1999PTC013295. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Infugen Pharma has 1 court case on record: 1 filed against it.
Infugen Pharma was incorporated on 04 February 1999, making it 27+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Infugen Pharma by revenue are Usan Pharmaceuticals Private Limited, Nemus Pharmaceuticals Private Limited, Cedric Pharmaceuticals Private Limited, Growmax Medicare Private Limited, Maple Cross Remedies Private Limited and 2 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Bharat Jagjivan Bhate was appointed as Director on 04 Feb 1999. Sandeep Jagjeevan Modi was appointed as Director on 04 Feb 1999.
Yes, Infugen Pharma is registered as an MSME under Udyam registration (number: UDYAM-MH-18-0048984).
Infugen Pharma can be reached through the website infugenpharma.com. Its registered office is in Sangli, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages